IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,507,342 | +63827.4% | 291,857 | -87.0% | 0.06% | -37.6% |
| Q1 2023 | $8,615 | -23.6% | 2,243,746 | -1.4% | 0.09% | -26.2% |
| Q4 2022 | $11,281 | -99.7% | 2,274,564 | +158.8% | 0.13% | +152.0% |
| Q3 2022 | $4,199,000 | +9.1% | 878,961 | +2.8% | 0.05% | +16.3% |
| Q2 2022 | $3,847,000 | -4.3% | 854,646 | +1.2% | 0.04% | +13.2% |
| Q1 2022 | $4,020,000 | – | 844,163 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |